CL2004001814A1 - COMPUESTOS DERIVADOS DE N-[3-(3-SUSTITUIDOS-PIRAZOLO-[1,5-a PIRIMIDIN-7-IL)-FENIL]-SULFONAMIDAS, PROCEDIMIENTO DE PREPARACION DE DICHO COMPUESTO Y DE INTERMEDIARIO; COMPOSICION FARMACEUTICA Y SU USO PARA TRATAR EPILEPSIA, ANSIEDAD, Y OTRAS. - Google Patents
COMPUESTOS DERIVADOS DE N-[3-(3-SUSTITUIDOS-PIRAZOLO-[1,5-a PIRIMIDIN-7-IL)-FENIL]-SULFONAMIDAS, PROCEDIMIENTO DE PREPARACION DE DICHO COMPUESTO Y DE INTERMEDIARIO; COMPOSICION FARMACEUTICA Y SU USO PARA TRATAR EPILEPSIA, ANSIEDAD, Y OTRAS.Info
- Publication number
- CL2004001814A1 CL2004001814A1 CL200401814A CL2004001814A CL2004001814A1 CL 2004001814 A1 CL2004001814 A1 CL 2004001814A1 CL 200401814 A CL200401814 A CL 200401814A CL 2004001814 A CL2004001814 A CL 2004001814A CL 2004001814 A1 CL2004001814 A1 CL 2004001814A1
- Authority
- CL
- Chile
- Prior art keywords
- procedure
- sulfonamids
- pirazolo
- pirimidin
- fenil
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P23/00—Anaesthetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
- A61P25/10—Antiepileptics; Anticonvulsants for petit-mal
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
- A61P25/12—Antiepileptics; Anticonvulsants for grand-mal
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Abstract
N-(3-(3-SUSTITUIDAS-PIRAZOLO(1,5-a)PIRIMIDIN-7-IL)-FENIL)-SULFONAMIDAS DE FORMULA I COMPOSICIONES QUE LOS CONTIENEN Y SU USO PARA EL TRATAMIENTO DE LAS ENFERMEDADES RELACIONADAS CON LA MODULACION DEL RECEPTOR GABA-A. EL PROCEDIMIENTO PARA OBTENERLAS CONSISTE EN HACER REACCIONAR COMPUESTOS DE LAS FORMULA II Y III COMPRENDE TAMBIEN EL PROCEDIMIENTO PARA LA OBTENCION DEL INTERMEDIO DE FORMULA VII QUE CONSISTE EN HACER REACCIONAR EL COMPUESTO DE LA FORMULA IV CON EL DIMETIL ACETAL DE LA N,N-DIMETILFORMAMIDA.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
ES200301746A ES2222813B1 (es) | 2003-07-24 | 2003-07-24 | N-(3-(3-sustituidas-pirazolo(1,5-a)pirimidin-7-il)-fenil)-sulfonamidas y composiciones y metodos relacionados. |
ES200401697A ES2245894B1 (es) | 2003-07-24 | 2004-07-12 | Mejoras en el objeto de la patente de invencion n.p200301746 que se refiere a "n-(3-(3-sustituidas-pirazolo(1,5-a)pirimidin-7-il)-fenil)-sulfonamidas y composiciones y metodos relacionados". |
Publications (1)
Publication Number | Publication Date |
---|---|
CL2004001814A1 true CL2004001814A1 (es) | 2005-06-03 |
Family
ID=34137682
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CL200401814A CL2004001814A1 (es) | 2003-07-24 | 2004-07-20 | COMPUESTOS DERIVADOS DE N-[3-(3-SUSTITUIDOS-PIRAZOLO-[1,5-a PIRIMIDIN-7-IL)-FENIL]-SULFONAMIDAS, PROCEDIMIENTO DE PREPARACION DE DICHO COMPUESTO Y DE INTERMEDIARIO; COMPOSICION FARMACEUTICA Y SU USO PARA TRATAR EPILEPSIA, ANSIEDAD, Y OTRAS. |
Country Status (30)
Country | Link |
---|---|
US (1) | US7947688B2 (es) |
EP (1) | EP1648897B1 (es) |
JP (1) | JP2006528608A (es) |
KR (1) | KR100840450B1 (es) |
CN (1) | CN100393721C (es) |
AR (1) | AR047017A1 (es) |
AT (1) | ATE417048T1 (es) |
AU (1) | AU2004263278B2 (es) |
BR (1) | BRPI0412826A (es) |
CA (1) | CA2532437C (es) |
CL (1) | CL2004001814A1 (es) |
DE (1) | DE602004018320D1 (es) |
DK (1) | DK1648897T3 (es) |
EA (1) | EA009519B1 (es) |
ES (2) | ES2222813B1 (es) |
HK (1) | HK1083844A1 (es) |
HR (1) | HRP20060009A2 (es) |
IL (1) | IL173252A0 (es) |
MA (1) | MA27944A1 (es) |
MX (1) | MXPA06000754A (es) |
NO (1) | NO20060580L (es) |
NZ (1) | NZ544349A (es) |
PA (1) | PA8607501A1 (es) |
PE (1) | PE20050254A1 (es) |
PL (1) | PL1648897T3 (es) |
PT (1) | PT1648897E (es) |
TW (1) | TWI340140B (es) |
UA (1) | UA81959C2 (es) |
UY (1) | UY28440A1 (es) |
WO (1) | WO2005014597A1 (es) |
Families Citing this family (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2006084835A1 (en) * | 2005-02-10 | 2006-08-17 | Ferrer Internacional, S. A. | N-(3-(imidazo [1,5-a]pyrimidin-4-yl)phenyl]-sulfonamides and n-[3-(imidazo[1,5-a]pyrimidin-4-yl)-phenyl]-carboxamides and their use as gabaa receptor modulators |
EP1736475A1 (en) * | 2005-06-21 | 2006-12-27 | Ferrer Internacional, S.A. | Halogenated pyrazolo[1,5-a]pyrimidines, processes, uses, compositions and intermediates |
JP2009530296A (ja) * | 2006-03-17 | 2009-08-27 | ワイス | ピラゾロ[1,5−a]ピリミジン誘導体およびその使用方法 |
EP1845098A1 (en) * | 2006-03-29 | 2007-10-17 | Ferrer Internacional, S.A. | Imidazo[1,2-b]pyridazines, their processes of preparation and their use as GABA receptor ligands |
EP1884516A1 (en) | 2006-08-04 | 2008-02-06 | Ferrer Internacional, S.A. | Pyrazolo[1,5-a]pyrimidines, processes, uses and compositions |
EP1956021A1 (en) | 2006-10-11 | 2008-08-13 | Ferrer Internacional, S.A. | Process for the manufacture of a crystalline pyrazolo[1,5-a]pyrimidine compound |
EP1921079A1 (en) * | 2006-11-08 | 2008-05-14 | Ferrer Internacional, S.A. | Amorphous form of N-{2-Fluoro-5-[3-(thiophene-2-carbonyl)-pyrazolo[1,5-a] pyrimidin-7-yl]-phenyl}-N-methyl-acetamide |
US8163903B2 (en) * | 2009-01-13 | 2012-04-24 | Interquim, S.A. | Process for the preparation of N-[5-(3-dimethylamino-acryloyl)-2-fluoro-phenyl]-N-methyl-acetamide |
WO2013039985A2 (en) * | 2011-09-12 | 2013-03-21 | The Johns Hopkins University | Serine protease inhibitors |
CN102807569B (zh) * | 2012-08-21 | 2015-02-25 | 四川大学 | 一种镇静催眠的化合物及其制备方法和用途 |
SG11201505493QA (en) * | 2013-02-21 | 2015-08-28 | Calitor Sciences Llc | Heteroaromatic compounds as pi3 kinase modulators |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
BE792533A (fr) * | 1971-12-09 | 1973-06-08 | Int Chem & Nuclear Corp | Nouvelles pyrazolo (1,5a) pyrimidines et leur procede de preparation |
US4626538A (en) * | 1983-06-23 | 1986-12-02 | American Cyanamid Company | [7-(3-disubstituted amino)phenyl]pyrazolo[1,5-a]pyrimidines |
US4654347A (en) * | 1983-06-23 | 1987-03-31 | American Cyanamid Company | Aryl and heteroaryl[[7-(3-disubstituted amino)phenyl]pyrazolo[1,5-a]pyrimidin-3-yl]methanones |
NZ208554A (en) * | 1983-06-23 | 1987-06-30 | American Cyanamid Co | (aryl and heteroaryl)-(7-(aryl and heteroaryl)-pyrazolo (1,5-a) pyrimidin-3-yl)-methanone derivatives and pharmaceutical compositions |
SG30590G (en) * | 1985-05-13 | 1995-09-18 | American Cyanamid Co | D7-(3-disubstituted amino) phenylaepyrazolod 1,5-aaepyrimidines |
EP0264773A1 (en) * | 1986-10-16 | 1988-04-27 | American Cyanamid Company | 4,5-dihydro and 4,5,6,7-tetrahydropyrazolo[1,5-a]pyrimidines |
DE4333705C2 (de) * | 1993-10-02 | 2003-10-30 | Guenter Ege | Arylmethylsubstituierte Pyrazolo-azine, insbesondere 3-Arylmethylpyrazolo[1,5-a]pyrimidine und Verfahren zur Herstellung von 8-Arylmethyl-pyrazolo[5,1-c][1,2,4]triazinen |
US5538977A (en) * | 1995-03-17 | 1996-07-23 | American Cyanamid Company | 3-Substituted-7-[3-(imidazol-1-yl)phenyl]-pyrazolo[1,5-a]pyrimidines |
DE60014339T8 (de) * | 1999-04-02 | 2006-04-27 | Neurogen Corp., Branford | Aryl- und heteroaryl-kondensierte aminoalkyl-imidazol-derivate: selektive modulatoren der gabaa-rezeptoren |
US6399621B1 (en) * | 1999-08-10 | 2002-06-04 | American Cyanamid Company | N-methyl-N-(3-{3-[2-thienylcarbonyl]-pyrazol-[1, 5-α]-pyrimidin-7-yl}phenyl)acetamide and compositions and methods related thereto |
-
2003
- 2003-07-24 ES ES200301746A patent/ES2222813B1/es not_active Expired - Fee Related
-
2004
- 2004-07-12 ES ES200401697A patent/ES2245894B1/es not_active Expired - Fee Related
- 2004-07-15 TW TW093121113A patent/TWI340140B/zh not_active IP Right Cessation
- 2004-07-20 PA PA20048607501A patent/PA8607501A1/es unknown
- 2004-07-20 CL CL200401814A patent/CL2004001814A1/es unknown
- 2004-07-22 DE DE602004018320T patent/DE602004018320D1/de active Active
- 2004-07-22 CN CNB2004800214537A patent/CN100393721C/zh not_active Expired - Fee Related
- 2004-07-22 CA CA2532437A patent/CA2532437C/en not_active Expired - Fee Related
- 2004-07-22 MX MXPA06000754A patent/MXPA06000754A/es active IP Right Grant
- 2004-07-22 US US10/562,559 patent/US7947688B2/en not_active Expired - Fee Related
- 2004-07-22 DK DK04741223T patent/DK1648897T3/da active
- 2004-07-22 PL PL04741223T patent/PL1648897T3/pl unknown
- 2004-07-22 UA UAA200600630A patent/UA81959C2/uk unknown
- 2004-07-22 NZ NZ544349A patent/NZ544349A/en not_active IP Right Cessation
- 2004-07-22 EP EP04741223A patent/EP1648897B1/en not_active Not-in-force
- 2004-07-22 EA EA200600316A patent/EA009519B1/ru not_active IP Right Cessation
- 2004-07-22 KR KR1020067001267A patent/KR100840450B1/ko not_active IP Right Cessation
- 2004-07-22 WO PCT/EP2004/008208 patent/WO2005014597A1/en active Application Filing
- 2004-07-22 JP JP2006520796A patent/JP2006528608A/ja active Pending
- 2004-07-22 PT PT04741223T patent/PT1648897E/pt unknown
- 2004-07-22 AT AT04741223T patent/ATE417048T1/de active
- 2004-07-22 BR BRPI0412826-5A patent/BRPI0412826A/pt not_active IP Right Cessation
- 2004-07-22 AU AU2004263278A patent/AU2004263278B2/en not_active Ceased
- 2004-07-23 AR ARP040102619A patent/AR047017A1/es unknown
- 2004-07-23 PE PE2004000710A patent/PE20050254A1/es not_active Application Discontinuation
- 2004-07-26 UY UY28440A patent/UY28440A1/es not_active Application Discontinuation
-
2006
- 2006-01-09 HR HR20060009A patent/HRP20060009A2/xx not_active Application Discontinuation
- 2006-01-19 IL IL173252A patent/IL173252A0/en unknown
- 2006-02-03 NO NO20060580A patent/NO20060580L/no not_active Application Discontinuation
- 2006-02-13 MA MA28797A patent/MA27944A1/fr unknown
- 2006-05-25 HK HK06106022.3A patent/HK1083844A1/xx not_active IP Right Cessation
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CL2004002050A1 (es) | Compuestos derivados de piridinonas sustituidas; su uso en el tratamiento de afecciones causadas o exacerbadas por actividad p38 map kinasa y/o tnf no regulada, tales como inflamaciones, tumores, sida y otros. | |
CU23464B7 (es) | (1,8)naftidirin-2-onas y compuestos relacionados para el tratamiento de la esquizofrenia | |
ECSP034428A (es) | Ciclopentanoindoles, composiciones conteniendo tales compuestos y su uso | |
AR045900A1 (es) | Compuesto glucocorticoesteroide, composiciones farmaceuticas que los contienen y su uso para el tratamiento de trastornos inflamatorios y/o alergicos. | |
UY28150A1 (es) | Agentes terapeuticos | |
UY29004A1 (es) | Compuestos derivados sustituídos de ácidos, glicina y alanina; procedimiento para su preparación y uso. | |
EA200700099A1 (ru) | Производные пиридина | |
ECSP003713A (es) | Derivados de purina | |
ECSP003712A (es) | Derivados de la purina | |
ECSP055680A (es) | Nuevos compuestos de imidazol como inhibidores del factor de crecimiento transformante (tgf) | |
EA200801011A1 (ru) | Производные пиразина как модуляторы натриевых каналов для лечения боли | |
ES2183937T3 (es) | Inhibidores de la adhesion celular. | |
UY27981A1 (es) | Nuevos compuestos de triazol como inhibidores del factor de crecimiento transformante (tgf) | |
ECSP055679A (es) | Derivados de pirazol como inhibidores del factor del crecimiento transformante (tgf) | |
ES2340502T3 (es) | Compuestos de 1,4,8-triazaespiro(4,5)decan-2-ona sustituidos para el tratamiento de la obesidad. | |
ECSP034811A (es) | Derivados heterocicliloxi-, -tioxi - y - aminobenzazole tales como ligandos 5-hidroxitriptamina-6 | |
UY28144A1 (es) | Agentes terapéuticos | |
UY28343A1 (es) | Derivados de 2-amino-piridina utiles para el tratamiento de enfermedades | |
GT200800227A (es) | Antagonistas del receptor de vanilloides del subtipo (vr1) y usos de los mismos | |
CY1109808T1 (el) | Αρυλινδενο-πυριδινες και αρυλινδενο-πυριμιδινες και η χρηση τους ως ανταγωνιστων των υποδοχεων αδενοσινης α2α | |
UY29003A1 (es) | Nuevos derivados de hidantoína, procesos para su preparación, composiciones farmacéuticas que los contienen y su uso en terapia | |
DOP2006000017A (es) | Pirazolopiridinas y sales de las mismas, una composición farmaceútica que comprende dichos compuestos, un método para prepararlos y su uso | |
ECSP088584A (es) | Nuevos derivados de benzimidazol como inhibidores del receptor vanilloide 1 (vrl) | |
ECSP045473A (es) | Derivados de 1-(aminoalquil)-3-sulfonilindol y 1-aminoalquil-3-sulfonilindazol como ligandos de 5-hidroxitriptamina-6 | |
CL2008003472A1 (es) | Compuestos derivados de 5-[3,3,3-trifluoro-2-hidroxi-1-arilpropil)amino]-1h-quinolin-2-ona, proceso para la preparacion de los mismos, compuestos intermediarios, composicion farmaceutica que comprende dicho compuesto; combinacion farmaceutica, y sus usos en el tratamiento de enfermedades inflamatorias. |